Stable Isotopes Product Detail
Home Stable Isotopes CS-T-96376

Daclatasvir RSSS Isomer-d3

Chemical Properties and Information

Product Code: CS-T-96376 Stable Isotopes
Daclatasvir RSSS Isomer-d3
API Family
--
Product Code
CS-T-96376

Daclatasvir RSSS Isomer-d3

Stable Isotopes
Stock Status: : Enquire Live

CAT No.
CS-T-96376
CAS No.
--
Molecular Formula
C40H47D3N8O6
Molecular Weight
741.89
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
-
Product Code
CS-T-96376
M.F.
C40H47D3N8O6
M.W.
741.89
Category
Stable Isotopes
Storage Condition
Refer MSDS for complete information.
IUPAC Name
Daclatasvir RSSS Isomer-d3
References
"Gao, M., et al.: Nature, 465(7294), 96 (2010); Bell, T. W., Chem. Med. Chem., 5(10), 1663 (2010)"
Synonyms
"N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-2,1-pyrrolidinediyl[1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester Stereoisomer-d3"
Application Notes
"Daclatasvir RSSS Isomer-d3 is the isotope labelled analog of Daclatasvir RSSS Isomer (D101515); an isomer of Daclatasvir (D101500) which is a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV)."
Hazard Compound
Refer MSDS for complete information.
Overview
"Daclatasvir RSSS Isomer-d3 is the isotope labelled analog of Daclatasvir RSSS Isomer (D101515); an isomer of Daclatasvir (D101500) which is a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV)."
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.